Abstract
Understanding how epidemics spread within societies is key for establishing adequate infection control responses. Dynamical models provide a means to translate surveillance data into predictions of future disease spread, yet many epidemic models do not capture empirically observed features of socialization. Here, we utilize a connection between sampling processes and their macroscopic equations to build an epidemic model that incorporates transmission heterogeneity, homophily, and awareness of the risk of infection. Our risk-SIR model captures how diseases tend to spread initially within more social subpopulations and sequentially spread to less social subpopulations. This dynamic complicates surveillance as many metrics become dynamic when comorbidities vary with socialization. We also show fast-growing lineages that emerge within highly social subpopulations can be misidentified as potential variants of concern, and that these lineages will transiently grow in frequency as they remain distributed among more social individuals. Together, we provide a simple framework for analysis of how socialization affects disease emergence and spread, and argue that this is necessary to contextualize epidemiologic parameters like the basic and time varying reproductive numbers based on sampling and stage of the outbreak.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon request to the authors
